Comparison of perindopril and enalapril in the treatment of essential hypertension
Youjun Li
Abstract
Youjun Li
Abstract
Objective:To compare the efficacy and safety of perindopril and enalapril in the treatment of essential hypertension.Methods:Sixtysix cases with essential hypertension were divided randomly into two groups:perindopril and enalapril.Treatment lasted for 24 weeks.Parameters of blood pressure was measured before and after treatment.Results:Blood pressure were significantly reduced in both groups.There was no significant difference in responder rates between perindopril treated patients(89.5%)and patients taking enalapril(81.5%).The trough to peak ratios of systolic and diastolic blood pressures of perindopril were greater than that of enalapril.Conclusion:Perindoprilonce daily is effective,safe and well tolerated in hypertensihe patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare the efficacy and safety of perindopril and enalapril in the treatment of essential hypertension.Methods:Sixtysix cases with essential hypertension were divided randomly into two groups:perindopril and enalapril.Treatment lasted for 24 weeks.Parameters of blood pressure was measured before and after treatment.Results:Blood pressure were significantly reduced in both groups.There was no significant difference in responder rates between perindopril treated patients(89.5%)and patients taking enalapril(81.5%).The trough to peak ratios of systolic and diastolic blood pressures of perindopril were greater than that of enalapril.Conclusion:Perindoprilonce daily is effective,safe and well tolerated in hypertensihe patients.
Key concepts: Perindopril, Enalapril, Medicine, Blood pressure, Essential hypertension, Internal medicine, Cardiology, Indapamide